Excited to share our study on RBC exchange transfusion in severe babesiosis, now in @JAMAInternalMed. With Peter Krause and collaborators across 82 hospitals, we found substantially improved clinical outcomes in severe disease.
https://t.co/s4XAcb4e2v
🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI @NicholasRebold@IDpharmresearch and many @SIDPharm 🌟s
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection #IDXposts#DOTS
https://t.co/FOh8iUXInq
Promising results from our investigator-initiated prospective study of a commercially available CMV T-cell immunity assay! @noufkmag, @BrownIDprogram, @eurofinsviracor https://t.co/RODlDbGcGX
Time to challenge the dogma of steroids for severe PJP? Our multicenter retrospective study of PJP in SOTRs led by Drs Hosseini-Moghaddam and Fishman did not find an association between steroids and mortality in SOTRs https://t.co/fvR0iS0yu3 @amjtransplant#IDTwitter
📣 Webinar ALERT! Thursday, Nov. 16th. 1pm EST
Register NOW for ‘A Paradigm of Precision Medicine: Clinical utilization of CMV inSIGHT™ T Cell Immunity Testing,’ presented by Dr. Dimitrios Farmakiotis.
💻 11/16 | 1:00pm EST
🦠 REGISTER 👇
🗣 @DFarmakiotis#IDtwitter#CMV
I was honored to present our research work under the lead of Dr. Farmakiotis @DFarmakiotis on the utility of CMV-specific T-cell mediated immunity panel (TCIP) to predict protection against CMV among kidney transplant recipients #IDWeek2023#IDWeekmtg#WeAreID#TxID
It was a huge honor to work on this important study - the RSV vaccine adds to our armamentarium to keep our older adults safe from the scourge of this important pathogen. Thanks to the dedicated @NM_Transplant research team for their support.
https://t.co/jD9RGBMixm
mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study | Open Forum Infectious Diseases | Oxford Academic Vaccines work led by @BrownMedicine MS @BrownIDprogram https://t.co/WJEhcNeFL7
mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study
✅ Just Accepted
🔓 Open Access
🔗 https://t.co/K9r2PhKBbs
IDSA COVID-19 OUTPATIENT TREATMENT GUIDELINES ROADMAP: High titer conv plasma for outpatient management of COVID-19 in the immunosuppressed @COVID19nCCC @mtmdphd https://t.co/2Zl7ZmxDOw
Deskins Candies Recalls Peanut Butter Fudge, Peanut Butter No Bake, Chocolate No Bake, and Peanut Butter Pinwheel Because of Possible Health Risk https://t.co/J2F3sInNUl‘MVpeanut-butter-fudge-peanut-butter-no-bake-chocolate-no-bake-and-peanut
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression https://t.co/ojsVluH6h5 Important work on #Paxlovid drug drug interactions, again with @BrownMedicine#trainee contribution. @BrownIDprogram